The company's shares were up 24% ahead of market's open on an FDA approval.
The EpiPen-maker has received a letter from the FDA about its manufacturing facility in Nashik, India.
David Hung will become Axovant's CEO after completing the $14 billion sale of Medivation to Pfizer.
Endo International slipped 5% ahead of market's open Friday.
Sycamore Partners' attempt to purchase divested dollar stores went poorly. Will the FTC believe Fred's can do better with Rite Aid spinoffs?
Positive phase three data was a boon for Trevena, but Synergy's "Poop Troop" put pressure on its stock.
The two companies initially agreed to an acquisition agreement in October 2015.
Investors are ticked off about the CEO's bonanza amid dismal results.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.